Rare deseases
The framework conditions for the national genome sequencing model project are in place. But which patients will actually benefit? And what needs to be implemented for the project to make the leap to standard care in 2029?
The framework conditions for the national genome sequencing model project are in place. But which patients will actually benefit? And what needs to be implemented for the project to make the leap to standard care in 2029?